Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Netscientific 'demonstrating a strong strategic direction' says broker

Netscientific is demonstrating a strong strategic direction against a challenging market backdrop and driving towards key value inflection points, profitable exits and new funding opportunities, said broker WH Ireland.

“Despite the modest year-end cash position, we remain reassured that the balance sheet is supported by potential proceeds of selling privately held and market quoted holdings, moving towards an evergreen model, and we retain our risked-based sum-of-the-parts fair valuation of NSCI of 180p per share.”

The group now has a portfolio of 24 companies and last year increased its portfolio value 35% to £41.8m (£31m), while the value of capital under advisory grew to £23.5m (£22.1m).

Shares were up 2% today at 70p.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK